SELECTED IMPORTANT SAFETY INFORMATION

Some people who have taken medicine like ATRIPLA have developed build up of lactic acid in the blood, which can be a serious medical emergency that can lead to death.
Some people who have taken medicines like ATRIPLA have developed
serious liver problems, with liver enlargement and fat in the liver, which can lead to death.
If you also have hepatitis B virus (HBV) infection and you stop taking ATRIPLA, your hepatitis may suddenly
get worse. ATRIPLA is not approved for the treatment of HBV.

ATRIPLA: in English| en español

Search:

information for healthcare professionals

Please click here for more information about these warnings, including signs and symptoms, and other Important Safety Information.

Questions to Ask Your Doctor

The following are some questions that may be helpful to you when discussing ATRIPLA with your doctor. Together, you can decide which treatment regimen might work best for you. Always discuss with your doctor all prescription and non-prescription medicines, vitamins, or herbal supplements you are taking or plan to take. It’s important to be honest and specific with your doctor to get the best possible results from your treatment.

1. Is ATRIPLA an appropriate regimen for me?

2. How will we know if ATRIPLA is working?

3. Is ATRIPLA the combination of SUSTIVA^® (efavirenz) and
TRUVADA^® (emtricitabine/tenofovir disoproxil fumarate)?

4. If I take ATRIPLA, will I have to take any other HIV meds?

5. What are the possible side effects of ATRIPLA?

6. If I experience side effects, what should I do?

7. What if I forget to take a dose of ATRIPLA?

8. How can I get help paying for my HIV medications?

9. Should I take ATRIPLA if I am pregnant or nursing?

ATRIPLA does not cure HIV-1 infection or AIDS and you may continue to experience illnesses associated with HIV-1 infection, including opportunistic infections.

See your healthcare provider regularly while taking ATRIPLA.

Please click here for Important Safety Information, including information on buildup of lactic acid in the blood, serious liver problems, and sudden worsening of hepatitis B virus.

Please send me information and updates.

Find an HIV/AIDS Service Organization near you.

Distance to search:

Enter your ZIP code:

Site Map | Contact Us | Privacy Policy | Terms of Use | Unsubscribe

Click here for ATRIPLA Full Prescribing Information.

(c) 2012 Bristol-Myers Squibb Company.

ATRIPLA and ATRIPLA Peer Advocate Network are registered trademarks of Bristol-Myers Squibb & Gilead Sciences, LLC. SUSTIVA is a registered trademark of Bristol-Myers Squibb Company. COMPLERA, EMTRIVA, GILEAD, GSI, HEPSERA, TRUVADA, and VIREAD are trademarks of Gilead Sciences, Inc., or its related companies. All other trademarks referenced herein are the property of their respective owners.

Patient models are used on this Web site. The information on this site is intended for residents of the United States who are 18 years of age or older. The content of this site is protected under applicable copyright and trademarks law.

This site may contain, from time to time, information related to various health, medical and fitness conditions, and their treatment. Such information is not meant to be a substitute for the advice provided by a physician or other medical professional. You should not use the information contained herein for diagnosing a health or fitness problem or disease. You should always consult a physician and/or a healthcare provider.

Your use of this information is subject to the terms and conditions of our Terms of Use and Privacy Policy.

697US12WA04601 07/12